2025 IND Trends and 2026 Clinical Trials Outlook
Introduction Global IND submissions surged in 2025, revealing key shifts in Clinical Trials design and strategy. Sponsors embraced new therapeutic modalities, biomarker-driven patient selection, and agile proof-of-concept trial designs, while regulators introduced accelerated pathways to expedite development. This article analyzes…